Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
SciSparc Ltd. ( (SPRC) ) has provided an announcement.
On November 27, 2025, SciSparc Ltd. announced a securities purchase agreement with institutional and accredited investors to issue 1,292,557 ordinary shares at $1.75 each, aiming to raise approximately $2.2 million. The proceeds will be used for working capital and general corporate purposes. This strategic financial move is expected to bolster SciSparc’s operational capabilities and enhance its market position in the biotechnology sector.
More about SciSparc Ltd.
SciSparc Ltd. is a company based in Tel Aviv, Israel, operating in the biotechnology industry. It focuses on developing therapies for the treatment of disorders related to the central nervous system.
Average Trading Volume: 5,321,859
Technical Sentiment Signal: Sell
Current Market Cap: $3.6M
See more data about SPRC stock on TipRanks’ Stock Analysis page.